[January 24, 2011]
Drugs for Neglected Diseases initiative (DNDi) and Cipla, jointly with Vimal, organised a symposium to discuss the use of Artemisin Combination Therapy in Myanmar.
[January 24, 2011]
[December 4, 2010]
New Delhi, India
In collaboration with partners from the Program on Global health and Technology Access of Duke University, DNDi organized a workshop on intellectual property and open innovation on 4th December 2010 in New Delhi, India. The workshop gathered around 50 participants including DNDi partners, representatives of Indian civil society and DNDi staff.
[December 3, 2010]
New Delhi, India
Like in 2009 in Nairobi, Drugs for Neglected Diseases initiative (DNDi) brought together more than 150 Indian and international health researchers, policy makers, experts from 22 countries on December 3rd, at the Constitutional Club in New Delhi for the 3rd International Partners meeting organized by DNDi in collaboration with Indian Council for Medical Research (ICMR), to stimulate greater regional research partnership to fight the most neglected diseases such as Kala-azar sleeping sickness, malaria and Chagas disease.
[November 3-7, 2010]
The Drugs for Neglected Diseases initiative (DNDi) will participate in several activities at ASTMH 2010, including a joint symposium with Central Drug Research Institute (CDRI) on Visheral Leishmaniasis (VL) in the Indian Continent, a second symposium on VL in East Africa, a satellite symposium on Challenges and Successes of the FACT Project through Innovative Partnerships for the development of Artesunate Combination Therapies for Malaria, as well as several oral presentations.
[August 15-20, 2010]
The Drugs for Neglected Diseases initiative (DNDi) participated in several activities at the XIIth International Congress of Parasitology (ICOPA) 2010: the organisation of two symposia, (Malaria and Drug Discovery), as well as a preview of the documentary “1$ for 1 life“.
[April 23, 2010]
ARTE channel broadcasted this documentary on malaria, neglected diseases, and DNDi (French and German versions). A documentary by the filmmaker Frédéric Laffont.
[February 22, 2010]
Washington DC, USA
In the US, the Obama Administration releases its 2011 budget asking Congress to approve $155M for the treatment of Neglected Tropical Diseases (NTDs), a $90M increase over 2010. DNDi and MSF are calling for the inclusion of deadly NTDs, such as HAT, VL, and Chagas disease and to include R&D for urgently needed new tools including drugs to replace outdated, toxic, expensive, and ineffective ones. On February 22nd, DNDi, MSF, and RTI hold a briefing on Capitol Hill to inform policymakers of this deadly neglect and the opportunities to save the lives of neglected people suffering from these diseases.
[February 18-20, 2010]
Pretoria, South Africa
The meeting addressed the problems and challenges faced by African countries in their quest to increase access to medicines and research for innovative products, and to stimulate production of medicines in Africa. DNDi presented the background need for strengthened regulatory capacity in Africa in the Plenary session, and also held a Regulatory workshop. DNDi and the George Institute took advantage of this meeting to launch their joint report: “Registering New Drugs: The African context”.
[November 18-22, 2009]
Washington DC, USA
The Drugs for Neglected Diseases initiative (DNDi) participated in several sessions of the ASTMH 2009 , including a joint symposium with sanofi-aventis on pharmacovigilance of new anti-malarials in the field, a satelllite symposium on ASMQ, the anti-malarial Fixed-Dose Combination of Artesunate-Mefloquine, as well as several oral presentations and posters.
[October 2, 2009]
Los Angeles, USA
On October 2, 2009, in Los Angeles, Médecins Sans Frontières/Doctors Without Borders (MSF), the Drugs for Neglected Diseases initiative (DNDi), and the UCLA Program in Global Health convened a one-day symposium on Chagas disease, bringing together clinical researchers, drug developers, health professionals, policymakers, donors and activists.
[October 1, 2009]
Santa Monica, California, USA
The Drugs for Neglected Diseases initiative (DNDi) and Doctors Without Borders/Médecins Sans Frontières (MSF) hosted a panel discussion moderated by Univision’s Julio Cesar Ortiz on Chagas disease, a largely ignored infectious disease that kills thousands every year in Latin America. Since its discovery 100 years ago, very little has been done for the millions of people infected with Chagas, including an estimated 300,000 in the US.
[September 21-25, 2009]
Drugs for Neglected Diseases initiative (DNDi) and World Health Organisation (WHO) held a joint symposium on “Progress Made and Challenges Ahead in Clinical Research and Development of New Treatments for Human African Trypanosomiasis” followed by a Public Event organized by DNDi, the HAT Platform, along with NECT partners to celebrate the availability of the NECT treatment (improved treatment for sleeping sickness).
[September 6-10, 2009]
Drugs for Neglected Diseases initiative (DNDi) and Médecins Sans Frontières (MSF) held a joint workshop at the most important European congress on tropical medicine to discuss the following topic: “Unfinished business on the road to elimination: experiences, needs, and priorities in accessing patients and adequate health tools to treat Chagas disease and sleeping sickness”
[September 3-4, 2009]
Buenos Aires, Argentina
The two-day international symposium organized by Mundo Sano Foundation is the biggest scientific meeting on Dengue Fever, Chagas Disease and other neglected diseases in Argentina. Many members of the Argentinean government were present, together with researches and students from several Latin American countries, to discuss and present tools and strategies to fight the challenges related to neglected diseases.
[September 2, 2009]
Amsterdam, The Netherlands
The Drugs for Neglected Diseases initiative (DNDi) and the Royal Tropical Institute (KIT) hosted an event to raise awareness for the need for research and development for better health tools and improved access for all Chagas’ patients. The event is part of the global campaign “Wake Up. Time to Treat Chagas Disease!” and brought a panel of experts covering the main aspects of Chagas’ diagnostics, medicines, field treatments etc., and a lively public discussion, chaired by Dr Pieter van Thiel, from the Amsterdam Medical Centre.
[July 8-10, 2009]
Rio de Janeiro, Brazil
A three-day international symposium organised by Fiocruz to celebrate the 100 years of Chagas disease discovery by Brazilian researcher, Carlos Chagas, gathered more than 750 international experts. Speakers from five South American countries – together with speakers from France, Canada and the US, including Institut Pasteur, MSF, and DNDi – covered many aspects of Chagas disease: its history, epidemiology, vector control, molecular biology, immunology, and clinical treatment. In parallel to this event, on July 09, DNDi and MSF launched the Chagas Campaign to raise awareness that more is needed to fight the disease: www.treatchagas.org
[July 6-9, 2009]
Geneva, Switzerland DNDi participated at ECOSOC’s Innovation Fair at the High-Level Segment meeting, which took place in Geneva. This meeting and all the “satellite” activities presented good opportunities to discuss research & development issues, especially in the neglected diseases sector. DNDi had a booth at ECOSOC’s Innovation Fair and made a presentation about the Leishmaniasis East Africa Platform (LEAP)
[June 24, 2009]
How to Strengthen Capacity in Africa for the Registration of New Drugs for Neglected Diseases? That was the topic discussed by more than 50 attendees at the workshop which was held during DNDi‘s 2nd Stakeholders’ and 3rd African Meetings, in Nairobi, Kenya.
[ June 23, 2009 ]
Like last year in New York, Drugs for Neglected Diseases initiative (DNDi) will bring together more than 150 scientists, researchers, academics and global health leaders from Africa, Asia, Europe, Latin America and North America on June 23, 2009, to discuss how international research partnerships can best develop and deliver new lifesaving drugs for neglected diseases.
[ May 18-21, 2009 ]
DNDi and iOWH hoeld panel sessions at BIO 2009.